These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 7521999

  • 1. [Tumor markers in prostate cancer].
    Kuriyama M.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF, Bentvelsen FM, Oosterom R, Schroeder FH.
    Scand J Urol Nephrol Suppl; 1991 Sep; 138():97-103. PubMed ID: 1723815
    [Abstract] [Full Text] [Related]

  • 3. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 4. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study of tumor markers in prostatic cancer].
    Ishihara Y, Fukagai T, Ohta K, Hiromoto Y, Hiramori M, Torii T, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063
    [Abstract] [Full Text] [Related]

  • 6. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K, Tanaka M, Kitagawa N, Kotake T, Yanagi S, Ito H.
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 9. Prostate specific antigen. Experimental and clinical observations.
    Huber PR, Schnell Y, Hering F, Rutishauser G.
    Scand J Urol Nephrol Suppl; 1987 Jun; 104():33-9. PubMed ID: 2449722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A.
    Scand J Urol Nephrol Suppl; 1994 Jun; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M, Kraljić I.
    Anticancer Res; 1997 Jun; 17(3A):1531-4. PubMed ID: 9179191
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y, Yoshki T, Okada K, Yoshida O, Yamamoto N, Sakatoku J, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
    [Abstract] [Full Text] [Related]

  • 17. Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer.
    Romppanen J, Haapalainen T, Punnonen K, Penttilä I.
    Anticancer Res; 2002 Sep; 22(1A):415-20. PubMed ID: 12017325
    [Abstract] [Full Text] [Related]

  • 18. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF, Mensink HJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1733-8. PubMed ID: 10494319
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Dec 21; 34(12):2143-8. PubMed ID: 2467543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.